The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm

References

• Monzón M, Oteiza C, Leiva J, et al. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagnostic microbiology and infectious disease. Diagn Microbiol Infect Dis 2002;44:319–24
   PubMed Web of Science ®Google Scholar
• Mathur T, Singhal S, Khan S, et al. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol 2006;24:25–9
   PubMedGoogle Scholar
• Eftekhar F, Dadaei T. Biofilm formation and detection of icaAB genes in clinical isolates of methicillin resistant Staphylococcus aureus. Iran J Basic Med Sci 2011;14:132–6
   Web of Science ®Google Scholar
• Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000;46:S47
   PubMed Web of Science ®Google Scholar
• Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005;57:1539–50
   PubMed Web of Science ®Google Scholar
• Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003;5:1213–19
   PubMed Web of Science ®Google Scholar
• Villain-Guillot P, Gualtieri M, Bastide L, Leonetti JP. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2007;51:3117–21
   PubMed Web of Science ®Google Scholar
• Estrela AB, Abraham WR. Combining biofilm-controlling compounds and antibiotics as a promising new way to control biofilm infections. Pharmaceuticals 2010;3:1374–93
   Google Scholar
• Karosi T, Sziklai I, Csomor P. Low-frequency ultrasound for biofilm disruption in chronic rhinosinusitis with nasal polyposis: in vitro pilot study. Laryngoscope 2013;123:17–23
   PubMed Web of Science ®Google Scholar
• Gagnon RF, Richards GK, Kostiner GB. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms. Adv Perit Dial 1994;10:189–92
   PubMedGoogle Scholar
• Cheow WS, Hadinoto K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology 2012;10:327–33
   Web of Science ®Google Scholar
• Kasimanickam RK, Ranjan A, Asokan GV, et al. Prevention and treatment of biofilms by hybrid- and nanotechnologies. Int J Nanomed 2013;8:2809–19
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm 1997;154:123–40
   Web of Science ®Google Scholar
• Alipour M, Suntres ZE, Lafrenie RM, Omri A. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. J Antimicrob Chemother 2010;65:684–93
   PubMed Web of Science ®Google Scholar
• Zhu CT, Xu YQ, Shi J, et al. Liposome combined porous β-TCP scaffold: preparation, characterization, and anti-biofilm activity. Drug Deliv 2010;17:391–98
   PubMed Web of Science ®Google Scholar
• Kim HJ, Michael Gias EL, Jones MN. The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf A Physicochem Eng Asp 1999;149:561–70
   Web of Science ®Google Scholar
• Malaekeh-Nikouei B, Jaafari MR, Tabassi SAS, Samiei A. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids Surf B Biointerfaces 2008;67:238–44
   PubMed Web of Science ®Google Scholar
• Malaekeh-Nikouei B, Davies N. Double loading of cyclosporine A in liposomes using cyclodextrin complexes. PDA J Pharm Sci Technol 2009;63:139–48
   PubMedGoogle Scholar
• Hemanth Kumar A, Chandra I, Geetha R, et al. A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine. Indian J Pharmacol 2004;36:231–3
   Google Scholar
• Vila MMDC, Oliveira RM, Gonçalves MM, Tubino M. Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals. Química Nova 2007;30:395–9
   Web of Science ®Google Scholar
• Giandalia G, De Caro V, Cordone L, Giannola LI. Trehalose–hydroxyethylcellulose microspheres containing vancomycin for topical drug delivery. Eur J Pharm Biopharm 2001;52:83–9
   PubMed Web of Science ®Google Scholar
• Clinical Institute LS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Appproved standard M7-A7; 2006
   Google Scholar
• Pitts B, Hamilton MA, Zelver N, Stewart PS. A microtiter-plate screening method for biofilm disinfection and removal. J Microbiol Methods 2003;54:269–76
   PubMed Web of Science ®Google Scholar
• Okajima Y, Kobayakawa S, Tsuji A, Tochikubo T. Biofilm formation by Staphylococcus epidermidis on intraocular lens material. Invest Ophthalmol Vis Sci 2006;47:2971–5
   PubMed Web of Science ®Google Scholar
• Wu WS, Chen CC, Chuang YC, et al. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect 2013;46:89–95
   PubMedGoogle Scholar
• Cerca N, Martins S, Cerca F, et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005;56:331–6
   PubMed Web of Science ®Google Scholar
• Peck KR, Kim SW, Jung SI, et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 2003;49:189–93
   PubMed Web of Science ®Google Scholar
• Simon V, Simon M. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis Suppl 1990;72:14–19
   PubMedGoogle Scholar
• Sanderson NM, Guo B, Jacob AE, et al. The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature. Biochim Biophys Acta 1996;1283:207–14
   PubMed Web of Science ®Google Scholar
• Kaszuba M, Robinson AM, Song YH, et al. The visualisation of the targeting of phospholipid liposomes to bacteria. Colloids Surf B Biointerfaces 1997;8:321–32
   Web of Science ®Google Scholar
• Jones MN, Song YH, Kaszuba M, Reboiras MD. The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide. J Drug Target 1997;5:25–34
   PubMed Web of Science ®Google Scholar
• Ahmed K, Muiruri PW, Jones GH, et al. The effect of grafted poly (ethylene glycol) on the electrophoretic properties of phospholipid liposomes and their adsorption to bacterial biofilms. Colloids Surf A Physicochem Eng Asp 2001;194:287–96
   Web of Science ®Google Scholar
• Jones MN, Kaszuba M, Reboiras MD, et al. The targeting of phospholipid liposomes to bacteria. Biochim Biophys Acta 1994;119:57–64
   Web of Science ®Google Scholar
• Soenen SJH, Brisson AR, De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 2009;30:3691–701
   PubMed Web of Science ®Google Scholar